Literature DB >> 16696314

Effect of PD I administration on dopamine receptors mRNAs expression in the lesioned striatum of PD rat model.

Yang Mei1, Shenggang Sun, Xuebing Cao.   

Abstract

To study the effect of PD I administration on dopamine receptors (DR1, DR2) mRNAs expression in the lesioned striatum of the PD rat model and confirm if PD I has the effect of dopamine receptor agonist. The PD rats with unilateral 6-hydroxydopamine lesioned were administrated with PD I, L-dopa methyl/benserazide, L-dopa methyl /benserazide/ PD I, normal saline respectively for 4 weeks and their behavioral changes were observed. Then the rats were sacrificed and RT-PCR technique was used to detect changes of dopamine receptors (DR1, DR2) mRNAs expression in the ipsilateral striatum 1 day after the last treatment. The results showed that treatment with PD I plus L-dopa resulted in a stable contralateral rotation behavior; treatment with L-dopa resulted in a progressively increased contralateral rotation behavior. Rotation behavior induced by anhydromorphine decreased with PD I or PD I plus L-dopa treatment. Treatment With L-dopa or PD I plus L-dopa, up-regulation of DR1 mRNA and down-regulation of DR2 mRNA were observed in the ipsilateral striatum which were more obvious than that treated with PD I or vehicle (P < 0.05). It was concluded that long-term treatment with PD I could alleviate the behavior of PD rats. PD I had no apparent effect on the dopamine receptors (DR1, DR2) mRNAs expression in the ipsilateral striatum and the PD I has no agonist effect on dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16696314     DOI: 10.1007/bf02896159

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.

Authors:  Marie-Paule Muriel; Gaël Orieux; Etienne C Hirsch
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

2.  Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation.

Authors:  Wen-Jun Hwang; Wei-Jen Yao; Shiaw-Pyng Wey; Lie-Hang Shen; Gann Ting
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

3.  In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias.

Authors:  N Turjanski; A J Lees; D J Brooks
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

4.  Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography.

Authors:  G Flores; J J Liang; A Sierra; D Martínez-Fong; R Quirion; J Aceves; L K Srivastava
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.

Authors:  A Antonini; J Schwarz; W H Oertel; O Pogarell; K L Leenders
Journal:  Mov Disord       Date:  1997-01       Impact factor: 10.338

6.  Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET.

Authors:  J Opacka-Juffry; S Ashworth; R G Ahier; S P Hume
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.